Merck KGaA (OTCMKTS:MKKGY) Shares Shorted: Short Interest Up 95.4% in September

Posted by Doug Wharley on Oct 1st, 2026

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 3,461 shares, an increase of 95.4% from the August 31st total of 1,771 shares. Based on an average daily volume of 323,326 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Merck KGaA Price Performance

Shares of Merck KGaA stock opened at $31.11 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.09 and a current ratio of 1.69. Merck KGaA has a 52-week low of $23.73 and a 52-week high of $34.19. The company has a fifty day moving average of $31.84 and a 200-day moving average of $29.83. The stock has a market capitalization of $20.10 billion, a price-to-earnings ratio of 16.04, a price-to-earnings-growth ratio of 2.96 and a beta of 0.96.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on MKKGY. UBS Group lowered shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. HSBC raised shares of Merck KGaA to a “hold” rating in a report on Monday, July 6th. Finally, Zacks Research lowered shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th. Six equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Merck KGaA presently has an average rating of “Hold”.

View Our Latest Stock Report on MKKGY

About Merck KGaA

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. The company operates independently from Merck & Co, Inc, the U.S.-based company that uses the Merck name in the United States and Canada.

Merck KGaA operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, analytical technologies and bioprocessing solutions used by pharmaceutical and biotechnology companies, academic institutions and industrial laboratories.